Nonclinical Safety Assessment of Morus alba L. Fruits: Study of 90-D Toxicity in Sprague Dawley Rats and Genotoxicity in Salmonella

被引:13
作者
Chang, Bo Yoon [1 ]
Kim, Seon Beom [2 ]
Lee, Mi Kyeong [2 ]
Park, Hyun [3 ,4 ]
Kim, Sung Yeon [1 ]
机构
[1] Wonkwang Univ, Inst Pharmaceut Res & Dev, Coll Pharm, Iksan 570749, Jeonbuk, South Korea
[2] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[3] Wonkwang Univ, Coll Med, Inst Zoonosis, Res Ctr, Iksan 570749, Jeonbuk, South Korea
[4] Wonkwang Univ, Coll Med, Dept Infect Biol, Iksan 570749, Jeonbuk, South Korea
基金
新加坡国家研究基金会;
关键词
genotoxicity; herbal safety; Morus alba L. fruit; SD rat; subchronic toxicity; ANTIOXIDANT ACTIVITY; FLAVONOIDS; INJURY;
D O I
10.1111/1750-3841.13285
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Morus alba L. is a traditional herb with a long history of consumption, both as an edible fruit and as medicine. However, its safety evaluation has not yet been established. The objective of this study was to evaluate subchronic oral toxicity and genotoxicity of M. alba L. fruits (MFE). The subchronic toxicity after daily oral administration of MFE at 0, 40, 200, and 1000 mg/kg for 90 d was examined in Sprague Dawley (SD) rats. MFE administration did not lead to death, adverse effects, change in food and water consumption, and body weight gain. Significant toxic effects were not found within the parameters of organ weight, biochemical values, and hematological and urine analysis between the control and the MFE group. The genotoxicity of MFE was assayed by Ames test in Salmonella typhimurium strains TA98, TA102, and TA1535. No genotoxicity was found in all the tested strains. Thus in this study, a no-observed-adverse-effect level for MFE in 90 d repeated oral toxicity study in rats was determined to be greater than 1000 mg/kg regardless of gender. The results also suggested that MFE does not have a genotoxicity potential.
引用
收藏
页码:T1328 / T1335
页数:8
相关论文
共 36 条
[1]  
Ajala M O, 2013, Niger Postgrad Med J, V20, P188
[2]   METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST [J].
AMES, BN ;
MCCANN, J ;
YAMASAKI, E .
MUTATION RESEARCH, 1975, 31 (06) :347-363
[3]  
[Anonymous], 2015, ALTERNAT MED, DOI DOI 10.1109/INTMAG.2015.7157778
[4]  
Barnes J, 1998, FOCUS ALTERN COMPLEM, V3, P43
[5]   Improved Chemotherapeutic Activity by Morus alba Fruits through Immune Response of Toll-Like Receptor 4 [J].
Chang, Bo Yoon ;
Kim, Seon Beom ;
Lee, Mi Kyeong ;
Park, Hyun ;
Kim, Sung Yeon .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10) :24139-24158
[6]  
Chang BoYoon Chang BoYoon, 2012, Korean Journal of Pharmacognosy, V43, P179
[7]   Morus alba and active compound oxyresveratrol exert anti-inflammatory activity via inhibition of leukocyte migration involving MEK/ERK signaling [J].
Chen, Yi-Ching ;
Tien, Yin-Jing ;
Chen, Chun-Houh ;
Beltran, Francesca N. ;
Amor, Evangeline C. ;
Wang, Ran-Juh ;
Wu, Den-Jen ;
Mettling, Clement ;
Lin, Yea-Lih ;
Yang, Wen-Chin .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13
[8]  
Choi Y.K., 2013, EVID-BASED COMPL ALT, V2013, P1
[9]   Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy [J].
Dejanova, B ;
Filipce, V ;
Dejanov, P ;
Sikole, A ;
Grozdanovski, R ;
Maleska, V .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (06) :484-486
[10]   Evidence-based medicine: A unified approach [J].
Eddy, DM .
HEALTH AFFAIRS, 2005, 24 (01) :9-17